8legs: Cancer

Your Followed Topics

#1 out of 3134.8K est. views

Latest development shows a preventive Lynch syndrome cancer vaccine is safe and immunogenic in a phase 1b/2 trial.
Participants developed a sufficient immune response that persisted for at least a year.
Heyink, a Lynch syndrome carrier, had three consecutive clear colonoscopies after vaccination.
The vaccine trains the immune system to recognize Lynch-specific proteins using a modified adenovirus.
Experts describe Lynch syndrome as a pan-cancer syndrome with risks across multiple organs.
MD Anderson researchers led the trial, with results suggesting potential broader use pending further trials.
Participants experienced mild, temporary side effects similar to a COVID-19 vaccine.
Heyink hopes the vaccine will be available for his children and future generations.
The trial reached recruitment goals quickly, reflecting strong interest across the globe.
Researchers emphasize more trials are needed to confirm effectiveness and gain approval.

Vote 1

#2 out of 3

health16h ago

Towle restarts chemotherapy after a months-long break taken during a clinical trial.
"now, after one chemo, i feel so gone" and "it's like you're walking around in a dream, and nothing feels real."
Towle describes memory loss and mood swings as part of chemotherapy's toll on her mind.
She hopes sharing the experience increases awareness for those facing similar side effects.
Towle has documented her cancer journey online since her 2023 diagnosis, aiming to reach affected communities.
The profile notes her audience reached 876,000 followers on TikTok at the time of the post.
Towle's experience highlights the mental health impact of cancer treatment beyond physical symptoms.
The story cites a Mayo Clinic reference to explain the cancer type Towle faces.
Towle's latest post was shared on TikTok on January 21, 2026, describing the experience.
The piece in People emphasizes her aim to reach audiences affected by side effects.

Vote 0

#3 out of 323.6K est. views100.00%

Five-year cancer survival averages have risen to 92% for breast cancer and 98% for prostate cancer in recent years.
Overall five-year survival across all cancers now averages 7 in 10, up over two decades.
Advances in treatments like immune checkpoint therapy and CAR T-cell therapy have boosted survival.
Early diagnosis through routine screening has contributed to longer survival periods.
Liver cancer and pancreatic cancer show notable survival gains in the last two decades.
The report covers changes since the 1990s with overall cancer death rates declining.
Researchers highlight that most recurrences occur within the first five years after diagnosis.
The analysis comes from the American Cancer Society’s 75th annual Cancer Statistics report.
New therapies are driving improved outcomes across multiple cancer types.

Vote 1

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.